BackCatalyst Pharmaceuticals Overview
Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Target Price

Explore Catalyst Pharmaceuticals's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$31.49

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-28H.C. Wainwright$31.50% upsideOpen
2026-05-07Stephens$321.6% upsideOpen
2025-11-07OppenheimerLeland Gershell$334.8% upsideOpen
2025-03-03Robert W. Baird$321.6% upsideOpen
2025-02-04Robert W. BairdJoel Beatty$2811.1% downsideOpen
2025-01-10H.C. WainwrightAndrew Fein$3511.1% upsideOpen
2022-12-21Truist Financial$1842.8% downsideOpen
2022-12-21H.C. Wainwright$2423.8% downsideOpen
2022-12-19Piper SandlerJoseph Catanzaro$2036.5% downsideOpen
2022-08-24Roth CapitalScott Henry$15.550.8% downsideOpen
2022-08-11Truist Financial$1746% downsideOpen
2022-08-11H.C. Wainwright$1842.8% downsideOpen

Catalyst Pharmaceuticals (CPRX) FAQ

Stockcircle tracks target price for Catalyst Pharmaceuticals (CPRX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Catalyst Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main CPRX overview so you can move from this figure to the surrounding analysis quickly.